BCR and Burkitt lymphoma: Given the known functions of LMP2A, which include signaling through the BCR pathway and modulation of cell death and proliferation in experimental models (Caldwell et al., 1998, Mancao and Hammerschmidt, 2007), its expression in BL would be consistent with the properties of this tumor.